The DOI matches its Crossref record; 209 of the 211 references it cites were found in a registry or an index.
Alzheimer Mechanisms and Therapeutic Strategies
Open accessAbstract
There are still no effective treatments to prevent, halt, or reverse Alzheimer's disease, but research advances over the past three decades could change this gloomy picture. Genetic studies demonstrate that the disease has multiple causes. Interdisciplinary approaches combining biochemistry, molecular and cell biology, and transgenic modeling have revealed some of its molecular mechanisms. Progress in chemistry, radiology, and systems biology is beginning to provide useful biomarkers, and the emergence of personalized medicine is poised to transform pharmaceutical development and clinical trials. However, investigative and drug development efforts should be diversified to fully address the multifactoriality of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“increases its cleavage by a stress-induced neuron-specific protease [7, 12, 16]”
From Neuronal Apolipoprotein E4 Expression Results in Proteome-Wide Alterations and Compromises Bioenergetic Capacity by Disrupting Mitochondrial Function (2019) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cell-specific toxicity is the result of neuron-specific apoE4 proteolysis [7, 12].”
From Neuronal Apolipoprotein E4 Expression Results in Proteome-Wide Alterations and Compromises Bioenergetic Capacity by Disrupting Mitochondrial Function (2019) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“in general, ApoE4 fragments are proposed to promote neuronal dysfunction, neurodegeneration and astrogliosis [11]”
From Apoe4 and Alzheimer’s Disease Pathogenesis—Mitochondrial Deregulation and Targeted Therapeutic Strategies (2023) · cites this paper as [11]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nevertheless, as previously mentioned in this review, some authors identified collagenase, MMP-9, neuron-specific α-chymotrypsin-like serine protease, cathepsin D and HtrA1 as some of the proteases that are able to cleave ApoE4 into neurotoxic fragments.”
From Apoe4 and Alzheimer’s Disease Pathogenesis—Mitochondrial Deregulation and Targeted Therapeutic Strategies (2023) · cites this paper as [11]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Current targeted therapeutic strategies have failed to slow down cognitive decline in AD (Graham et al., 2017; Huang and Mucke, 2012), raising concerns about these hypotheses and calling for a broad understanding of molecular and cellular components in AD brain, at both asymptomatic and symptomatic stages during the disease progression (De Strooper and Karran, 2016).”
From Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer’s Disease Progression (2020) · cites this paper as Huang and Mucke, 2012
The cited source says what the claim attributes to it.
In the citing paper
“Apolipoprotein E4 (APOE4) is the strongest genetic risk factor for late-onset Alzheimer’s disease (LOAD)1–3.”
From The APOE-R136S mutation protects against APOE4-driven tau pathology, neurodegeneration, and neuroinflammation (2023) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“This is significant because astrocytes are the primary source of APOE production in the brain, and disease-related phenotypes are influenced by the interactions between astrocyte-secreted APOE and neurons (Huang, 2010; Huang and Mucke, 2012).”
From Isogenic human stem cell models reveal mutation-dependent protective mechanisms of APOE3 Christchurch (2026) · cites this paper as Huang and Mucke, 2012
The cited source says what the claim attributes to it.
In the citing paper
“lowers the age of onset [4–14]”
From Neuronal Apolipoprotein E4 Expression Results in Proteome-Wide Alterations and Compromises Bioenergetic Capacity by Disrupting Mitochondrial Function (2019) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“ApoE4 increases risk for AD”
From Neuronal Apolipoprotein E4 Expression Results in Proteome-Wide Alterations and Compromises Bioenergetic Capacity by Disrupting Mitochondrial Function (2019) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“Currently, there is no treatment to stop, prevent, or reverse AD, and recent advances with monoclonal antibody therapy targeting plaques, although controversial, might at best only slow progression (Huang and Mucke, 2012; Selkoe, 2019; Sevigny et al., 2016).”
From Inhibiting USP16 rescues stem cell aging and memory in an Alzheimer’s model (2022) · cites this paper as Huang and Mucke, 2012
In the citing paper
“The pathogenesis of the protein abnormalities, the β‐amyloid (Aβ) peptides that aggregate to form the amyloid fibrils of the neuritic plaque, and the hyperphosphorylated tau that forms the neurofibrillary tangles, is now much better understood 137 .”
From Mental health care for older adults: recent advances and new directions in clinical practice and research (2022) · cites this paper as [137]
In the citing paper
“Apolipoprotein (apo) E4, an isoform of the APOE gene in humans, is the major genetic risk factor for late-onset familial and sporadic AD [4–8], which account for most AD cases.”
From Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease (2019) · cites this paper as [4]
In the citing paper
“Both of these pathologies are exacerbated by the presence of apoE4 [4–7, 12].”
From Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease (2019) · cites this paper as [4]
In the citing paper
“ApoE4 increases the risk and decreases the age of onset of AD in a gene dose dependent manner [4–11].”
From Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease (2019) · cites this paper as [4]
In the citing paper
“Overall, it has been demonstrated, both in vivo and in vitro, that apoE plays major roles in AD pathogenesis in both an Aβ-dependent and independent manner, and different cellular sources of apoE4 may contribute in distinct ways to AD pathogenesis [4–8, 12–14, 21, 22].”
From Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease (2019) · cites this paper as [4]
In the citing paper
“The apoE3 and apoE4 amino acid sequences differ only at position 112 where apoE4 has an Arg instead of a Cys.”
From Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease (2019) · cites this paper as [4]
In the citing paper
“These fragments escape the secretory pathway and enter the cytosol, where they stimulate tau-phosphorylation and interact with mitochondria, leading to mitochondrial dysfunction and neurodegeneration [4].”
From Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease (2019) · cites this paper as [4]
In the citing paper
“Currently, there is no treatment to stop, prevent, or reverse AD, and recent advances with monoclonal antibody therapy targeting plaques, although controversial, might at best only slow progression (Huang and Mucke, 2012; Selkoe, 2019; Sevigny et al., 2016).”
From Inhibiting USP16 rescues stem cell aging and memory in an Alzheimer’s model (2022) · cites this paper as Huang and Mucke, 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
The projected effect of risk factor reduction on Alzheimer's disease prevalence
Barnes, D. E., & Yaffe, K. S. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70072-2 · Cited by 2,846
Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
Braak, H., Thal, D. R., Ghebremedhin, E., & Del Tredici, K. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318232a379 · Cited by 2,194
Karran, E., Mercken, M., & Strooper, B. D. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3505 · Cited by 2,188
Shumaker, S. A., Legault, C., Rapp, S. R., Thal, L., Wallace, R. B., Ockene, J. K., Hendrix, S. L., Jones III, B. N., Assaf, A. R., Jackson, R. D., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2651 · Cited by 2,178
Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders
Ballatore, C., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2194 · Cited by 2,174
The clinical use of structural MRI in Alzheimer disease
Frisoni, G. B., Fox, N. C., Jack, C. R., Scheltens, P., & Thompson, P. M. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.215 · Cited by 2,113
Flagged first, then by citations
2 of the 211 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Verret, 2012, Key role of interneuronal impairments in Alzheimer's disease-related neural network and cognitive dysfunction, Cell, 149
Cited by
Sorted by citations
Items 501–600 of 1,007
Mechanistic role of boswellic acids in Alzheimer’s disease: Emphasis on anti-inflammatory properties
Siddiqui, A., Shah, Z., Jahan, R. N., Othman, I., & Kumari, Y. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112250 · Cited by 54
Zhao, H., WANG, Z.-C., WANG, K.-F., & Chen, X. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3781 · Cited by 53
Yang, T., Wang, J., Sun, Q., Hibar, D. P., Jahanshad, N., Liu, L., Wang, Y., Zhan, L., Thompson, P. M., & Ye, J. (2015) · IEEE International Symposium on Biomedical Imaging (ISBI) · doi:10.1109/isbi.2015.7164036 · Cited by 53
Esfandiari, E., Karimipour, M., Mardani, M., Alaei, H., Ghanadian, M., Kazemi, M., Mohammadnejad, D., Hosseini, N., & Esmaeili, A. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23319 · Cited by 54
Stumm, C., Hiebel, C., Hanstein, R., Purrio, M., Nagel, H., Conrad, A., Lutz, B., Behl, C., & Clement, A. B. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.05.027 · Cited by 54
Deficiency of GDNF Receptor GFRα1 in Alzheimer's Neurons Results in Neuronal Death
Konishi, Y., Yang, L., He, P., Lindholm, K., Lu, B., Li, R., & Shen, Y. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.2582-13.2014 · Cited by 56
The Alzheimer’s Disease γ-Secretase Generates Higher 42:40 Ratios for β-Amyloid Than for p3 Peptides
Siegel, G., Gerber, H., Koch, P., Oliver, B., Fraering, P. C., & Rajendran, L. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.034 · Cited by 53
Physical Activity in Preventing Alzheimer’s Disease and Cognitive Decline: A Narrative Review
Brini, S., Sohrabi, H. R., Peiffer, J. J., Karrasch, M., Hämäläinen, H., Martins, R. N., & Fairchild, T. J. (2017) · Sports Medicine · doi:10.1007/s40279-017-0787-y · Cited by 62
Arora, H., Ramesh, M., Rajasekhar, K., & Govindaraju, T. (2020) · Bulletin of the Chemical Society of Japan · doi:10.1246/bcsj.20190356 · Cited by 53
Jeon, S. G., Yoo, A., Chun, D. W., Hong, S. B., Chung, H., Kim, J.-I., & Moon, M. (2020) · Aging and Disease · doi:10.14336/ad.2019.0718 · Cited by 57
Махаева, Г. Ф., Lushchekina, S. V., Ковалева, Н. В., Astakhova, T. Y., Boltneva, N. P., Рудакова, Е. В., Serebryakova, O. G., Proshin, A. N., Serkov, I. V., Трофимова, Т. П., et al. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.104974 · Cited by 53
Gao, J., Inagaki, Y., Li, X., Kokudo, N., & Tang, W. (2013) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2013.v7.2.46 · Cited by 52
Feinberg, H., Saldanha, J. W., Diep, L., Goel, A. S., Widom, A., Veldman, G. M., Weis, W. I., Schenk, D., & Basi, G. S. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt261 · Cited by 52
Neuregulin 1 improves cognitive deficits and neuropathology in an Alzheimer’s disease model
Xu, J., de Winter, F., Farrokhi, C. B., Rockenstein, E. M., Mante, M., Adame, A., Cook, J. R., Jin, X., Masliah, E., & Lee, K. (2016) · Scientific Reports · doi:10.1038/srep31692 · Cited by 51
Five-Year Longitudinal Brain Volume Change in Healthy Elders at Genetic Risk for Alzheimer’s Disease
Reiter, K. E., Nielson, K. A., Durgerian, S., Woodard, J. L., Smith, J. C., Seidenberg, M., Kelly, D. A., & Rao, S. M. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160504 · Cited by 52
Bi, R., Zhang, W., Zhang, D., Xu, M., Fan, Y., Hu, Q.-X., Jiang, H., Tan, L., Li, T., Fang, Y., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0144-3 · Cited by 54
LVFFARK-PEG-Stabilized Black Phosphorus Nanosheets Potently Inhibit Amyloid-β Fibrillogenesis
Yang, J., Liu, W., Sun, Y. P., & Dong, X. (2020) · Langmuir · doi:10.1021/acs.langmuir.9b03612 · Cited by 52
Long, Z., Chen, J., Zhao, Y., Zhou, W. H., Yao, Q., Wang, Y., & He, G. (2020) · Aging · doi:10.18632/aging.103305 · Cited by 55
Zhao, L., Meng, F., Li, Y., Liu, S., Xu, M., Chu, F., Li, C., Yang, X., & Luo, L. (2023) · Advanced Materials · doi:10.1002/adma.202210879 · Cited by 50
Synergistic Actions of Microglia and Astrocytes in the Progression of Alzheimer's Disease
Bouvier, D. S., & Murai, K. K. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-143156 · Cited by 52
Cellular Prion Protein as a Therapeutic Target in Alzheimer's Disease
Laurén, J. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130950 · Cited by 55
The role of Thyrotropin Releasing Hormone in aging and neurodegenerative diseases
Daimon, C. M., Chirdon, P., Maudsley, S. R., & Martin, B. (2013) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.7726/ajad.2013.1003 · Cited by 50
Hippocampal Neural Disinhibition Causes Attentional and Memory Deficits
McGarrity, S., Mason, R., Fone, K. C. F., Pezze, M. A., & Bast, T. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw247 · Cited by 59
Zhen, J., Qian, Y., Weng, X., Su, W., Zhang, J., Cai, L., Dong, L., An, H., Su, R., Wang, J., et al. (2017) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.07.002 · Cited by 52
Magalhães, T. N. C., Weiler, M., Teixeira, C. V. L., Hayata, T., Moraes, A. S., Boldrini, V. D. O., dos Santos, L. M., de Campos, B. M., de Rezende, T. J. R., Joaquim, H. P. G., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0795-9 · Cited by 51
Zhou, L., Liao, W., Zeng, H., Yao, Y., Chen, X., & Ding, K. (2018) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.08.050 · Cited by 51
Curcumin as a Therapeutic Option in Retinal Diseases
López-Malo, D., Villarón-Casales, C., Alarcón-Jiménez, J., Miranda, M., Díaz-Llopis, M., Romero, F. J., & Villar, V. M. (2020) · Antioxidants · doi:10.3390/antiox9010048 · Cited by 51
Rodrigues, B. D. S., Kanekiyo, T., & Singh, J. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00218 · Cited by 51
Losev, Y., Paul, A., Frenkel-Pinter, M., Abu-Hussein, M., Khalaila, I., Gazit, E., & Segal, D. (2019) · Scientific Reports · doi:10.1038/s41598-019-39218-x · Cited by 50
Modulation of the Aβ peptide aggregation pathway by KP1019 limits Aβ-associated neurotoxicity
Jones, M. R., Mu, C., Wang, M. C. P., Webb, M. I., Walsby, C. J., & Storr, T. (2015) · Metallomics · doi:10.1039/c4mt00252k · Cited by 50
Beck, T. N., Nicolas, E., Kopp, M. C., & Golemis, E. A. (2014) · Oncoscience · doi:10.18632/oncoscience.64 · Cited by 50
Yu, W., Yu, W., Yang, Y., & Lü, Y. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.602781 · Cited by 50
Towards universal therapeutics for memory disorders
Sun, M., Nelson, T. J., & Alkon, D. L. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.04.004 · Cited by 51
Bazan, N. G. (2012) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2012.08.008 · Cited by 54
Xu, B. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.10.008 · Cited by 52
Carroll, V., Truillet, C., Shen, B., Flavell, R. R., Shao, X., Evans, M. J., VanBrocklin, H. F., Scott, P. J. H., Chin, F. T., & Wilson, D. M. (2016) · Chemical Communications · doi:10.1039/c6cc00895j · Cited by 50
Wang, E., Zhu, H., Wang, X., Gower, A. C., Wallack, M., Blusztajn, J. K., Kowall, N. W., & Qiu, W. Q. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160677 · Cited by 50
Li, Q., Wang, Y., Peng, W.-J., Jia, Y., Tang, J., Li, W., Zhang, J. H., & Yang, J. (2019) · Cell Transplantation · doi:10.1177/0963689719857085 · Cited by 51
Effects of ApoE on intracellular calcium levels and apoptosis of neurons after mechanical injury
Jiang, L., Zhong, J., Dou, X., Cheng, C., Huang, Z., & Sun, X. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.06.005 · Cited by 50
Paranjpe, M. D., Belonwu, S., Wang, J. K., Oskotsky, T., Gupta, A., Taubes, A., Zalocusky, K. A., Paranjpe, I., Glicksberg, B. S., Huang, Y., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.735611 · Cited by 49
Self-citationRossini, P. M., Miraglia, F., Alù, F., Cotelli, M., Ferreri, F., Iorio, R. D., Iodice, F., & Vecchio, F. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10020034 · Cited by 49
Chung, P. J., Choi, M. C., Miller, H. P., Feinstein, H. E., Raviv, U., Li, Y., Wilson, L., Feinstein, S. C., & Safinya, C. R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1513172112 · Cited by 49
Gong, W.-G., Wang, Y., Zhou, H., Li, X.-L., Bai, F., Ren, Q., & Zhang, Z. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9781-x · Cited by 49
Pluta, R. M., Kocki, J., Ułamek-Kozioł, M., Petniak, A., Gil-Kulik, P., Januszewski, S., Bogucki, J., Jabłoński, M., Brzozowska, J., Furmaga-Jabłońska, W., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151102 · Cited by 49
Gx-50 Inhibits Neuroinflammation via α7 nAChR Activation of the JAK2/STAT3 and PI3K/AKT Pathways
Shi, S., Liang, D., Bao, M., Xie, Y., Xu, W., Wang, L., Wang, Z., & Qiao, Z. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150963 · Cited by 50
Hofer, T., & Perry, G. L. (2016) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2016.06.005 · Cited by 49
Current status and future prospects of stem cell therapy in Alzheimer’s disease
Fu, X., Zeng, L., Zhang, F., Jiang, J., Zhang, J.-T., & Niu, H. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.265544 · Cited by 53
Cerebrospinal fluid lipidomics for biomarkers of Alzheimer's disease
Byeon, S. K., Madugundu, A. K., Jain, A., Bhat, F. A., Jung, J. H., Renuse, S., Darrow, J. A., Bakker, A., Albert, M., Moghekar, A., et al. (2021) · Molecular Omics · doi:10.1039/d0mo00186d · Cited by 50
Chen, L., van Zijl, P. C. M., Wei, Z., Lu, H., Duan, W., Wong, P. C., Li, T., & Xu, J. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.118071 · Cited by 48
Palmer, D. D., Dumont, J. R., Dexter, T. D., Prado, M. A. M., Finger, E. C., Bussey, T. J., & Saksida, L. M. (2021) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2021.107443 · Cited by 54
Kwon, J., Seo, Y. H., Lee, J.-E., Seo, E. K., Li, S., Guo, Y., Hong, S., Park, S., & Lee, D. (2015) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00508 · Cited by 48
Genetic susceptibility to accelerated cognitive decline in the US Health and Retirement Study
Zhang, C., & Pierce, B. L. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.12.021 · Cited by 49
Development of dual targeting inhibitors against aggregations of amyloid-β and tau protein
Fuse, S., Matsumura, K., Fujita, Y., Sugimoto, H., & Takahashi, T. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.07.095 · Cited by 48
Bignante, E. A., Heredia, F., Morfini, G. A., & Lorenzo, A. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.021 · Cited by 50
Icariin Prevents Amyloid Beta-Induced Apoptosis via the PI3K/Akt Pathway in PC-12 Cells
Zhang, D., Wang, Z., Sheng, C., Peng, W., Hui, S., Gong, W., & Chen, S. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/235265 · Cited by 48
Chen, J., Zhang, D., Sun, Y., Zhao, Y., Zhao, K., Pu, D., & Xiao, Q. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.01.027 · Cited by 48
Yang, J., Hu, C., Guo, N., Dutta, J., Vaina, L. M., Johnson, K. A., Sepulcre, J., Fakhri, G. E., & Li, Q. (2017) · Scientific Reports · doi:10.1038/s41598-017-13339-7 · Cited by 50
Hou, S., Gu, R., & Wei, D. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00452 · Cited by 47
Traditional Oriental Medicines and Alzheimer’s Disease
Jeon, S. G., Song, E. J., Lee, D., Park, J., Nam, Y., Kim, J.-I., & Moon, M. (2018) · Aging and Disease · doi:10.14336/ad.2018.0328 · Cited by 48
Martín‐Belmonte, A., Aguado, C., Alfaro‐Ruiz, R., Moreno‐Martínez, A. E., de la Ossa, L., Hernández, J. M., Buisson, A., Früh, S., Bettler, B., Shigemoto, R., et al. (2019) · Brain Pathology · doi:10.1111/bpa.12802 · Cited by 50
Lv, G., Sun, A., Wang, M., Wei, P., Li, R., & Yi, T. (2020) · Chemical Communications · doi:10.1039/c9cc09233a · Cited by 48
Human iPSC-Based Modeling of Central Nerve System Disorders for Drug Discovery
Lu, Q., & Julia, T. C. W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031203 · Cited by 49
Yang, X., Xu, L., Le, L., Chen, Y.-H., You, Y., Gao, Y., Liu, Y., Yang, L., Tong, K., Chen, D., et al. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00639-1 · Cited by 46
Friend or foe: Lactate in neurodegenerative diseases
Wang, M., Zhou, Y., Li, W., Zhu, L., & Liu, D. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102452 · Cited by 48
Caberlotto, L., Lauria, M., Nguyen, T.-P., & Scotti, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078919 · Cited by 46
Gülcan, H. O., Ünlü, S., Esiringü, İ., Erçeti̇n, T., Şahin, Y., Öz, D., & Sahin, M. F. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.08.016 · Cited by 47
Rarity of the Alzheimer Disease–ProtectiveAPPA673T Variant in the United States
Wang, L.-S., Naj, A. C., Graham, R., Crane, P. K., Kunkle, B. W., Cruchaga, C., Murcia, J. D. G., Cannon‐Albright, L., Baldwin, C. T., Zetterberg, H., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.2157 · Cited by 47
Lu, X., Li, Y., Wang, W., Chen, S., Liu, T., Jia, D., Quan, X., Sun, D., Chang, A. K., & Gao, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086753 · Cited by 47
Stromal regulation of embryonic and postnatal mammary epithelial development and differentiation
Howard, B. A., & Lu, P. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.01.004 · Cited by 50
Brain metabolism and Alzheimer's disease: The prospect of a metabolite-based therapy
Thomas, S. C., Alhasawi, A. A., Appanna, V. D., Auger, C., & Appanna, V. D. (2014) · The journal of nutrition health & aging · doi:10.1007/s12603-014-0511-7 · Cited by 51
Nava-Mesa, M. O., Jiménez‐Díaz, L., Yajeya, J., & Navarro‐López, J. D. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00117 · Cited by 45
LRRK2 regulates retrograde synaptic compensation at the Drosophila neuromuscular junction
Penney, J., Tsurudome, K., Liao, E. H., Kauwe, G., Gray, L. A., Yanagiya, A., Calderon, M. R., Sonenberg, N., & Haghighi, A. P. (2016) · Nature Communications · doi:10.1038/ncomms12188 · Cited by 48
Comparison of neurotoxicity of different aggregated forms of Aβ40, Aβ42 and Aβ43 in cell cultures
Fu, L., Sun, Y., Guo, Y., Chen, Y., Yu, B., Zhang, H., Wu, J., Yu, X., Kong, W., & Wu, H. (2017) · Journal of Peptide Science · doi:10.1002/psc.2975 · Cited by 47
Current Perspectives regarding Stem Cell-Based Therapy for Alzheimer’s Disease
Kwak, K.-A., Lee, S., Yang, J.-Y., & Park, Y. (2018) · Stem Cells International · doi:10.1155/2018/6392986 · Cited by 50
Coelho, D. S., Schwartz, S., Merino, M. M., Hauert, B., Topfel, B., Tièche, C. C., Rhiner, C., & Moreno, E. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.11.098 · Cited by 47
Wisessaowapak, C., Visitnonthachai, D., Watcharasit, P., & Satayavivad, J. (2021) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2021.103626 · Cited by 47
Haptoglobin Interacts with Apolipoprotein E and Beta-Amyloid and Influences Their Crosstalk
Spagnuolo, M. S., Maresca, B., Marca, V. L., Carrizzo, A., Veronesi, C., Cupidi, C., Piccoli, T., Maletta, R., Bruni, A. C., Abrescia, P., et al. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500099f · Cited by 47
Chiam, J. T. W., Dobson, R., Kiddle, S. J., & Sattlecker, M. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140816 · Cited by 48
Ultra rapid in vivo screening for anti-Alzheimer anti-amyloid drugs
Espargaró, A., Medina, A., Pietro, O. D., Muñoz‐Torrero, D., & Sabaté, R. (2016) · Scientific Reports · doi:10.1038/srep23349 · Cited by 47
Ameliorative effect of Noni fruit extract on streptozotocin-induced memory impairment in mice
Pachauri, S. D., Verma, P. R. P., Dwivedi, A. K., Tota, S., Khandelwal, K., Saxena, J. K., & Nath, C. (2013) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283637a51 · Cited by 46
AβPP/PS1 Transgenic Mice Show Sex Differences in the Cerebellum Associated with Aging
Ordóñez‐Gutiérrez, L., Fernandez-Perez, I., Herrera, J. L., Anton, M., Benito‐Cuesta, I., & Wandosell, F. G. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160572 · Cited by 47
Nho, K. T., Nudelman, K. N. H., Allen, M., Hodges, A., Kim, S., Risacher, S. L., Apostolova, L. G., Lin, K., Lunnon, K., Wang, X., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12092 · Cited by 48
Akhoon, B. A., Choudhary, S., Tiwari, H., Kumar, A., Barik, M. R., Rathor, L., Pandey, R., & Nargotra, A. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00496 · Cited by 46
Sharma, A., & Dey, P. (2021) · Genomics · doi:10.1016/j.ygeno.2021.04.028 · Cited by 46
Xiao, Y. M., Dai, Y., Li, L., Geng, F., Xu, Y., Wang, J., Wang, S., & Zhao, J. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111651 · Cited by 45
A Survey on Continual Semantic Segmentation: Theory, Challenge, Method and Application
Yuan, B., & Zhao, D. (2024) · IEEE Transactions on Pattern Analysis and Machine Intelligence · doi:10.1109/tpami.2024.3446949 · Cited by 59
Quinn, S. D., Dalgarno, P. A., Cameron, R. T., Hedley, G. J., Hacker, C., Lucocq, J. M., Baillie, G. S., Samuel, I. D. W., & Penedo, J. C. (2013) · Molecular BioSystems · doi:10.1039/c3mb70272c · Cited by 46
Tian, Y., Guo, S., Zhang, Y., Xu, Y., Zhao, P., & Zhao, X. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9825-2 · Cited by 45
Deane, C. A. S., & Brown, I. R. (2016) · Cell Stress and Chaperones · doi:10.1007/s12192-016-0708-2 · Cited by 48
Alzheimer’s Disease: From Genetic Variants to the Distinct Pathological Mechanisms
Sun, Q., Xie, N., Tang, B., Li, R., & Shen, Y. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00319 · Cited by 46
Xu, M., Li, R., Li, X., Lv, G., Li, S., Sun, A., Zhou, Y., & Yi, T. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb01012b · Cited by 45
Chiquita, S., Campos, E. J., Castelhano, J., Ribeiro, M., Sereno, J., Moreira, P. I., Castelo-Branco, M. S., & Ambrósio, A. F. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0542-8 · Cited by 44
Alzheimer’s as a Systems-Level Disease Involving the Interplay of Multiple Cellular Networks
Castrillo, J. I., & Oliver, S. G. (2016) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2627-5_1 · Cited by 44
Sun, P.-Y., Liu, J., Hu, J.-N., Tu, Y.-F., Jiang, Q., Jia, Y.-J., Sun, H.-L., Chen, S.-H., Xin, J.-Y., Yu, Z.-Y., et al. (2024) · Science Advances · doi:10.1126/sciadv.adl1123 · Cited by 46
Tong, L. M., Yoon, S. Y., Andrews-Zwilling, Y., Yang, A., Lin, V., Lei, H., & Huang, Y. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.3815-15.2016 · Cited by 43
Self-citationIs membrane homeostasis the missing link between inflammation and neurodegenerative diseases?
de Groot, N. S., & Torrent, M. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2038-4 · Cited by 45
Neural stem cells could serve as a therapeutic material for age-related neurodegenerative diseases
Suksuphew, S. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i2.502 · Cited by 46
Martorell, P., Llopis, S., González, N., Ramón, D., Serrano, G., Torrens, A., Serrano, J. M., Navarro, M., & Genovés, S. (2016) · Food Science & Nutrition · doi:10.1002/fsn3.388 · Cited by 44
Yang, S., Pascual-Guiral, S., Landete, R. P., Giménez‐Llort, L., Baltrons, M. A., Arancio, O., Palacio, J. R., Clos, M. V., Yuste, V. J., & Bayascas, J. R. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00435 · Cited by 46
Ahmad, S., Bannister, C. A., van der Lee, S. J., Vojinović, D., Adams, H. H. H., Ramírez, A., Escott‐Price, V., Sims, R., Baker, E. A., Williams, J. H., et al. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.01.005 · Cited by 46
Metadata
- Authors
- Huang, Y., & Mucke, L.
- Affiliations
- Gladstone Institutes (US)
- Corresponding author
- Mucke, Lennart
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2012-03
- Volume
- 148
- Issue
- 6
- Pages
- 1204-1222
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC3319071
- OpenAlex
- W2002181764
- Cited by
- 1,758
- References
- 211
- Citations by year
- 2026: 37 · 2025: 80 · 2024: 78 · 2023: 104 · 2022: 113 · 2021: 127 · 2020: 148 · 2019: 149 · 2018: 160 · 2017: 149 · 2016: 168 · 2015: 143 · 2014: 135 · 2013: 127 · 2012: 39
- FWCI
- 15.31
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (AG011385, AG022074, P01AG022074)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, disease mechanisms, treatment options, genetic risk factors, transgenic animal models, biomarkers, personalized medicine, drug development, complex diseases
- MeSH terms
- Alzheimer Disease, Animals, Cognition, gamma-Aminobutyric Acid, Humans, Amyloid beta-Protein Precursor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
